Mechanism of action and pharmacokinetics
As a representative of 14-membered macrolides, clarithromycin inhibits protein synthesis in the microbial cell. Compared to baseline erythromycin, semi-synthetic clarithromycin possesses improved pharmacokinetic properties: it is stable in acidic environments, is excellently absorbed from the gastrointestinal tract, and food intake does not significantly affect its absorption. The drug achieves high tissue concentrations and is prescribed with a convenient dosing schedule of every 12 hours (orally or intravenously).
It is important to consider the metabolic profile of the drug. Clarithromycin acts as a potent inhibitor of cytochrome P450 isoenzymes (CYP3A4 / CYP3A5 and CYP1A2). This accounts for its ability to enter into significant drug interactions with substrates of these enzymes (cardiovascular drugs, statins, anticoagulants, and psychotropic agents).
Pharmacological effects and spectrum of activity
The drug exhibits pronounced high activity against intracellular pathogens (Chlamydia, Mycoplasma, Legionella). Its antimicrobial spectrum covers gram-positive cocci, causative agents of pertussis, diphtheria, as well as a number of specific microorganisms. Due to its tissue penetration, macrolides are used for infections of the respiratory tract, ENT organs, skin, and soft tissues.
Clinical indications
Clarithromycin has classic indications for macrolides, as well as a number of unique therapeutic areas:
- Respiratory and ENT infections: streptococcal tonsillopharyngitis, atypical pneumonias, pertussis, diphtheria.
- Gastroenterology: an essential component of combination eradication regimens for Helicobacter pylori in the treatment of gastric and duodenal ulcer disease (in combination with PPIs and amoxicillin).
- Mycobacterioses: treatment and prophylaxis of opportunistic infections in HIV caused by Mycobacterium avium.
- Alternative prophylaxis: year-round prophylaxis of rheumatic fever in patients with confirmed penicillin allergies.
Side effects and administration features
Being an inhibitor of cytochrome CYP3A4, clarithromycin can slow down the metabolism of many drugs (e.g., warfarin, cardiovascular drugs, certain psychotropics), increasing their blood concentration and the risk of toxic effects. Adverse reactions typical of antibiotics are possible from the gastrointestinal tract and other systems. When prescribing, the physician must cross-reference the patient's concurrent medication list to avoid pharmacokinetic conflicts.
Prescription writing rules
In accordance with the prescription reference book, the drug is available in tablet forms of 0.25 and 0.5 g. The standard administration regimen involves taking 0.25 or 0.5 g orally twice a day (the interval between doses is 12 hours).
Briefly: answers to topical questions
What is the exact mechanism of action of clarithromycin on the microbial cell?
Clarithromycin belongs to the macrolide group and has a bacteriostatic type of action. Its molecular target is the 50S subunit of the bacterial ribosome. The drug binds to a specific ligand within the ribosomal tunnel at the translocation stage. Because of this, the movement of the formed peptide from the A-site to the P-site is blocked, and the release of synthesized peptides from the ribosome is also disrupted. In mycobacterioses, inhibition of protein synthesis in the organism's organelles is hypothesized.
What specific side effects, other than gastrointestinal ones, does clarithromycin cause?
In addition to dyspeptic disorders, clarithromycin can cause allergic reactions and organotoxicity. Specific side effects include hepatotoxicity manifested as cholestatic hepatitis and elevated plasma transaminases, as well as ototoxicity manifesting as hearing impairment. With prolonged use of macrolides, risks such as hearing loss and cardiotoxicity are noted.
Cla-RITH-romycin: RITHm of administration strictly every 12 hours (twice a day).
Class and exam questions
What is the main pharmacokinetic advantage of clarithromycin over natural macrolides?
Improved GI absorption, stability in an acidic environment, and achievement of high tissue concentrations with a convenient twice-daily dosing regimen.
What is the role of clarithromycin in gastroenterology?
It is used in combination with proton pump inhibitors and amoxicillin for the eradication of Helicobacter pylori in peptic ulcer disease.
Is clarithromycin an inducer or inhibitor of CYP3A4 isoenzymes?
Clarithromycin is an inhibitor of CYP3A4 / CYP3A5 isoenzymes, which is important to consider when assessing drug interactions.
What else to study on this topic
- Comparative pharmacokinetics of 14-, 15-, and 16-membered macrolides
- Mechanisms of drug interactions via the cytochrome P450 system
- Modern regimens for Helicobacter pylori eradication therapy
- Prevention and treatment of mycobacterial infections in immunodeficiencies
- Cross-resistance between macrolides and ketolides (telithromycin)
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Full study guide on "Clarithromycin" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.